XM does not provide services to residents of the United States of America.
C
C

Clariant

News

Swiss trade surplus at CHF 4.578 bln in August

TABLE-Swiss trade surplus at CHF 4.578 bln in August Sept 19 (Reuters) - Switzerland ran a merchandise trade surplus of 4.578 billion Swiss francs in August, the Federal Customs Office said on Thursday. KEY FIGURES (millions of Swiss francs) August 2024 July 2024 Imports 15.912 19.215 Exports 20.491 24.092 Balance 4.578 4.877 The figures exclude precious metals and stones, works of art and antiques.
C
L
N
R
R
S

Clariant To Divest Industrial Park Fechenheim For EUR 95 Mln

BRIEF-Clariant To Divest Industrial Park Fechenheim For EUR 95 Mln Sept 17 (Reuters) - CLARIANT AG CLN.S : SELLS THE REAL ESTATE PROPERTY “INDUSTRIAL PARK FECHENHEIM” TO DIVEST INDUSTRIAL PARK FECHENHEIM FOR EUR 95 MILLION TRANSACTION EXPECTED TO CLOSE IN 2025 EXPECTS CHF 70 MILLION BOOK GAIN FROM SALE PROCEEDS TO BE USED TO REDUCE DEBT AND STR
C

Air Liquide, Novo Nordisk, Syensqo

EUROPE RESEARCH ROUNDUP- Air Liquide, Novo Nordisk, Syensqo Sept 5 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Air Liquide, Novo Nordisk and Syensqo, on Thursday. HIGHLIGHTS * Air Liquide AIRP.PA : Morgan Stanley cuts to underweight from equal-weight * Lanxess AG LXSG.DE : Morgan Stanley raises to overweight from underweight * Novo Nordisk NOVOb.CO : JP Morgan raises target price to DKK 1050 from DKK 950 * Swiss Life Holding AG
A
A
A
A
B
B
C
E
K
L
N
W
A
A
A
S
S

Arkema, Man Group, Shell

EUROPE RESEARCH ROUNDUP- Arkema, Man Group, Shell Aug 2 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Arkema, Man Group and Shell, on Friday. HIGHLIGHTS * Arkema SA AKE.PA : HSBC raises target price to EUR 105 from EUR 103 * Berkeley Group BKGH.L : Jefferies raises target price to 4,936p from 4,834p * Diageo Plc DGE.L : Morgan Stanley cuts target price to 2200p from 2380p * Man Group Plc EMG.L : Peel Hunt cuts to add from buy * Sh
A
A
A
A
A
B
B
B
B
B
C
C
C
D
E
E
M
R
S
S
U
A
B
T

Belgium's Syensqo on track for worst day ever after top end forecast cut

UPDATE 3-Belgium's Syensqo on track for worst day ever after top end forecast cut Annual EBITDA seen in 1.4 bln to 1.475 bln euros range Q2 EBITDA 378 mln euros vs. 383 mln euros consensus Updates share move, adds Syensqo and JPM comments By Alban Kacher and Leo Marchandon Aug 1 (Reuters) - Syensqo's SYENS.BR shares fell 6% on Thursday after the company lowered the top end of its annual core profit and free cash flow forecast, as it does not expect a broader demand recovery in the final six mont
C
S

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.